Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103387587B details high-yield Entecavir intermediate synthesis. Offers supply chain reliability and cost reduction for pharmaceutical manufacturing partners.
Patent CN102174007A details a cost-effective industrial method for DPP-IV inhibitor intermediates using cyanuric chloride, offering significant supply chain advantages.
Novel one-pot copper-catalyzed method converts CBD to CBN efficiently. Offers cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel deoxyfluorination process for Azivudine intermediate offering high purity and safety for pharmaceutical supply chains. Enables cost reduction and scalable manufacturing for global buyers.
Novel CsF catalyzed synthesis ensures high purity alpha anomer. Reduces purification costs for pharmaceutical intermediates manufacturing.
Patent CN102174007A details a cost-effective route for [2-(2-cyano-pyrrolidine-1-yl)-2-oxo-ethyl]-tert-butyl carbamate using cyanuric chloride dehydration.
Patent CN105348167A details a novel methanol-based purification method achieving 99.9% purity. This ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113292633B enables catalyst-free visible light hydrazine modification. Offers high purity unnatural amino acids with reduced manufacturing costs and scalable supply chain reliability.
Patent CN114853711A reveals a novel copper-catalyzed one-pot method for converting CBD to CBN, offering significant cost reduction and scalability for pharmaceutical manufacturers.
Novel Pd-catalyzed domino reaction for indole derivatives. Mild conditions, high yield, scalable for pharma intermediates. Reliable supply chain solutions.
Patent CN108048438B reveals a novel halohydrin dehalogenase mutant for efficient Atorvastatin side chain synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Patent CN102250077B reveals a mild, scalable route for rivaroxaban intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN116239645B reveals a high-yield photochemical route for Dydrogesterone. Discover cost-effective manufacturing and reliable supply chain solutions.
Explore novel macrocyclic TRK/ALK/ROS1 inhibitors from patent CN111171049B. Overcome drug resistance with high-purity pharmaceutical intermediates and scalable synthesis routes.
Patent CN1709864A discloses a high-yield asymmetric synthesis for Taxol side chains using low-cost glycolic acid and chiral tert-butyl sulfinamide, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN101104609B discloses a mild reductive amination route for Solanesyl polyamine derivatives, offering high yields and scalable production for oncology drug discovery.
Discover the advanced atmospheric pressure synthesis of (2S)-indoline-2-carboxylic acid. A cost-effective, high-purity route for Perindopril intermediates suitable for industrial scale-up.
Patent CN111548317A reveals a novel Efavirenz synthesis using Zinc Chloride, offering significant cost reduction and improved yield for pharmaceutical intermediate manufacturing.
Novel patent CN104557793B offers high-yield Carfilzomib intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.